Gino Santini - Net Worth and Insider Trading
Gino Santini Net Worth
The estimated net worth of Gino Santini is at least $46 Million dollars as of 2023-06-09. Gino Santini is the Sr.VP, Corp. Strategy & Policy of Eli Lilly and Co and owns about 89,010 shares of Eli Lilly and Co (LLY) stock worth over $40 Million. Gino Santini is also the Director of Horizon Therapeutics PLC and owns about 63,303 shares of Horizon Therapeutics PLC (HZNP) stock worth over $6 Million. Details can be seen in Gino Santini's Latest Holdings Summary section.
Transaction Summary of Gino Santini
Gino Santini Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gino Santini owns 7 companies in total, including Horizon Therapeutics PLC (HZNP) , AMAG Pharmaceuticals Inc (AMAG) , and Intercept Pharmaceuticals Inc (ICPT) among others .
Click here to see the complete history of Gino Santini’s form 4 insider trades.
Insider Ownership Summary of Gino Santini
|Ticker||Comapny||Transaction Date||Type of Owner|
|HZNP||Horizon Therapeutics PLC||2012-03-06||director|
|AMAG||AMAG Pharmaceuticals Inc||2020-06-02||director|
|ICPT||Intercept Pharmaceuticals Inc||2020-05-28||director|
|COLL||Collegium Pharmaceutical Inc||2022-05-19||director|
|ALNAQ||Allena Pharmaceuticals Inc||2017-11-01||director|
|VTAE||Vitae Pharmaceuticals Inc||2016-10-25||director|
|LLY||Eli Lilly and Co||2004-01-01||President & US Operations|
Gino Santini Latest Holdings Summary
Gino Santini currently owns a total of 2 stocks. Among these stocks, Gino Santini owns 89,010 shares of Eli Lilly and Co (LLY) as of December 15, 2005, with a value of $40 Million and a weighting of 86.31%. Gino Santini also owns 63,303 shares of Horizon Therapeutics PLC (HZNP) as of March 1, 2021, with a value of $6 Million and a weighting of 13.69%.
Latest Holdings of Gino Santini
|Ticker||Comapny||Latest Transaction Date||Shares Owned||Current Price ($)||Current Value ($)|
|LLY||Eli Lilly and Co||2005-12-15||89,010||445.66||39,668,197|
|HZNP||Horizon Therapeutics PLC||2021-03-01||63,303||99.42||6,293,584|
Holding Weightings of Gino Santini
Gino Santini Form 4 Trading Tracker
According to the SEC Form 4 filings, Gino Santini has made a total of 0 transactions in Eli Lilly and Co (LLY) over the past 5 years. The most-recent trade in Eli Lilly and Co is the sale of 5,000 shares on December 15, 2005, which brought Gino Santini around $280,700.
According to the SEC Form 4 filings, Gino Santini has made a total of 1 transactions in Horizon Therapeutics PLC (HZNP) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Horizon Therapeutics PLC is the sale of 12,000 shares on March 1, 2021, which brought Gino Santini around $1 Million.
Insider Trading History of Gino Santini
Gino Santini Trading Performance
Gino Santini Ownership Network
Ownership Network List of Gino Santini
Ownership Network Relation of Gino Santini
Gino Santini Owned Company Details
What does Horizon Therapeutics PLC do?
Horizon Therapeutics PLC is a biotechnology company. The company is focused on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. Some of its pipeline products include UPLIZNA; HZN-825; Dazodalibep; Daxdilimab; TEPEZZA and others.
Who are the key executives at Horizon Therapeutics PLC?
Gino Santini is the director of Horizon Therapeutics PLC. Other key executives at Horizon Therapeutics PLC include Chief Accounting Officer Patrick Mcilvenny , Chief Commercial Officer Jacopo Leonardi , and EVP & Chief Financial Officer Aaron Cox .
Horizon Therapeutics PLC (HZNP) Insider Trades Summary
Over the past 18 months, Gino Santini made no insider transaction in Horizon Therapeutics PLC (HZNP). Other recent insider transactions involving Horizon Therapeutics PLC (HZNP) include a net sale of 600,000 shares made by Timothy P Walbert , a net sale of 72,210 shares made by Andy Pasternak , and a net sale of 405,553 shares made by Paul W. Hoelscher .
In summary, during the past 3 months, insiders sold 0 shares of Horizon Therapeutics PLC (HZNP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,265,596 shares of Horizon Therapeutics PLC (HZNP) were sold and 745 shares were bought by its insiders, resulting in a net sale of 1,264,851 shares.
Horizon Therapeutics PLC (HZNP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Horizon Therapeutics PLC Insider Transactions
Gino Santini Mailing Address
Above is the net worth, insider trading, and ownership report for Gino Santini. You might contact Gino Santini via mailing address: C/o Amag Pharmaceuticals, Inc., 1100 Winter Street, Waltham Ma 02451.